Cargando…
PI3K inhibitors: review and new strategies
The search is on for effective specific inhibitors for PI3Kα mutants. PI3Kα, a critical lipid kinase, has two subunits, catalytic and inhibitory. PIK3CA, the gene that encodes the p110α catalytic subunit is a highly mutated protein in cancer. Dysregulation of PI3Kα signalling is commonly associated...
Autores principales: | Zhang, Mingzhen, Jang, Hyunbum, Nussinov, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472334/ https://www.ncbi.nlm.nih.gov/pubmed/32953006 http://dx.doi.org/10.1039/d0sc01676d |
Ejemplares similares
-
The mechanism of PI3Kα activation at the atomic level
por: Zhang, Mingzhen, et al.
Publicado: (2019) -
The mechanism of Raf activation through dimerization
por: Zhang, Mingzhen, et al.
Publicado: (2021) -
Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention
por: Nussinov, Ruth, et al.
Publicado: (2018) -
Does Ras Activate Raf and PI3K Allosterically?
por: Nussinov, Ruth, et al.
Publicado: (2019) -
Strategy toward
Kinase-Selective Drug Discovery
por: Zhang, Mingzhen, et al.
Publicado: (2023)